Overcoming challenges hindering potency within the tumour microenvironment to enhance the efficacy of cell therapies for solid tumours
04 May 2026
Cell Therapy Development
- Can we effectively modulate the immunosuppressive tumor microenvironment?
- Can we engineer cell therapies that are resilient within the TME?
- Do combination approaches with synergistic effects represent a viable path forward?
- Can biomarkers, patient selection strategies, and preclinical models be leveraged to improve current therapies?
